Health Care VC Waiting for Stem Cell Market to Grow

September 14th, 2006 |

 
Share this post:
Facebook | Twitter | Google+ | LinkedIn | Pinterest | Reddit | Email
 
This post can be linked to directly with the following short URL:


 
The audio player code can be copied in different sizes:
144p, 240p, 360p, 480p, 540p, Other


 
The audio player code can be used without the image as follows:


 
This audio file can be linked to by copying the following URL:


 
Download the audio file.
 
Subscribe:
Connected Social Media - iTunes | Spotify | Google | Stitcher | TuneIn | Twitter | RSS Feed | Email
 

Despite President Bush’s veto of the embryonic stem cell bill almost two months ago, many venture capitalists consider the stem cell market to be viable… though just not yet for some investors. When and why will a venture capitalist invest in a stem cell company? How does the venture industry view the stem cell controversy? Jennifer Jones of PodTech.net talks with Dr. Edgar Engleman, managing partner of Vivo Ventures, and probes their investment strategy and perspective today.

Tags: , ,
 
Posted in: Connected Social Media, Dow Jones VentureWire, Healthcare, Tech Conferences and Events, Technology